Vitamin D receptor has antiproliferative effects in pulmonary arterial hypertension, but receptor expression is downregulated ...

Advancements and Projections in the Global Pulmonary Arterial Hypertension Market: Insights, Trends, Opportunities, and ...

An independent data monitoring committee has recommended terminating the ZENITH study early based on the results.

Two industry-sponsored studies investiaged needs of people with pulmonary hypertesion and interstitial lung disease.

The Global Pulmonary Arterial Hypertension (PAH) Treatment Market is set for steady growth, with an estimated market size of ...

Patients continued taking their medications for pulmonary arterial hypertension (PAH) when symptoms appeared to improve, ...

Positive study results for Winrevair could help the drugmaker achieve sales growth past top-seller Keytruda’s upcoming patent ...

On Monday, Merck & Co Inc (NYSE:MRK) revealed topline results from the Phase 3 ZENITH study evaluating Winrevair (sotatercept ...

Royalty Corporation now owns an economic interest in seralutinib, a Phase 3 asset being studied in pulmonary arterial hypertension ...

Pulmonary hypertension (PH), a serious lung and heart condition, elevates blood pressure in lung arteries, causing shortness ...